This program is amazing
According to clinical trial data for semaglutide: nausea (up to 44% of patients) and diarrhoea (~30%) are the top complaints , followed by vomiting (~24%), constipation, and general stomach discomfort
Clinical studies suggest that Tirzepatide may offer more rapid and significant fat loss than Semaglutide, thanks to its dual-hormone activation
This hormone plays a key role in regulating blood sugar levels, appetite, and digestion
Combined with semaglutide gastric emptying delay, very high fat intake can cause nausea, bloating, and reflux that makes eating feel genuinely unpleasant
Some people may experience no digestive symptoms, while others may need additional support during the first few weeks of treatment